| 000 | 01125 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515035319.0 | ||
| 264 | 0 | _c20060824 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a1523-3774 | ||
| 024 | 7 |
_a10.1007/s11926-996-0029-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLee, Susan J | |
| 245 | 0 | 0 |
_aNew developments in clinically relevant mechanisms and treatment of hyperuricemia. _h[electronic resource] |
| 260 |
_bCurrent rheumatology reports _cJun 2006 |
||
| 300 |
_a224-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aFebuxostat |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperuricemia _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aThiazoles _xtherapeutic use |
| 650 | 0 | 4 |
_aUrate Oxidase _xmetabolism |
| 650 | 0 | 4 |
_aUric Acid _xmetabolism |
| 650 | 0 | 4 |
_aUricosuric Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aXanthine Oxidase _xantagonists & inhibitors |
| 700 | 1 | _aTerkeltaub, Robert A | |
| 773 | 0 |
_tCurrent rheumatology reports _gvol. 8 _gno. 3 _gp. 224-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11926-996-0029-z _zAvailable from publisher's website |
| 999 |
_c16488780 _d16488780 |
||